Riskpilot← Back to searchSign inGet full accessTESTDIG ApS
APSActiveCVR 32157955Gammel Strandvej 18AWholesale of pharmaceutical and medical goods · NACE 4646Est. 20092 employeeswww.testdig.dk
Revenue 2025
DKK 2,5M
+35% vs 2024
EBITDA margin
57.6%
+29% vs 2024
Equity ratio
92.7%
Financial strength
Net profit 2025
DKK 1,2M
+22% vs 2024
| Revenue | DKK 2,5M | +35% |
| EBITDA | DKK 1,5M | +29% |
| Net profit | DKK 1,2M | +22% |
| Total assets | DKK 6,2M | +5% |
| Equity | DKK 5,7M | +4% |
| Employees | 2 | — |
Legal name
TESTDIG ApS
CVR number
32157955
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. maj 2009
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive engros- og detailhandel med diagnosetest og apparater.
Address
Gammel Strandvej 18A
Phone
+4540444540
Email
info@testdig.dk
Website
www.testdig.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 564 | -721 | 1.172 | 1.264 | 1.050 | 1.380 | 1.610 | 1.617 | 2.032 | 3.332 | 2.704 | 2.066 | 1.880 | 2.546 |
| Staff expenses | -33 | -366 | -476 | -598 | -690 | -896 | -1.009 | -927 | -986 | -932 | -927 | -904 | -742 | -1.080 |
| EBITDA | 530 | -355 | 696 | 666 | 360 | 485 | 601 | 691 | 1.046 | 2.400 | 1.777 | 1.162 | 1.138 | 1.466 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -2 | -8 | -8 | -8 | -8 | -6 | -0 | -0 |
| EBIT | 530 | -355 | 696 | 666 | 360 | 485 | 599 | 683 | 1.038 | 2.392 | 1.769 | 1.156 | 1.138 | 1.466 |
| Net financials | -6 | -3 | -0 | -116 | -4 | 293 | 184 | 39 | 36 | 924 | 82 | -94 | 82 | 38 |
| Profit before tax | 525 | -173 | 696 | 549 | 356 | 778 | 783 | 722 | 1.074 | 3.316 | 1.851 | 1.062 | 1.220 | 1.504 |
| Tax | 131 | 90 | 173 | 157 | 80 | 137 | 138 | 133 | 229 | 608 | 389 | 256 | 251 | 324 |
| Net profit | 393 | -263 | 523 | 392 | 275 | 641 | 645 | 589 | 845 | 2.708 | 1.462 | 806 | 969 | 1.180 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.146 | 1.237 | 2.007 | 2.455 | 2.729 | 3.490 | 4.188 | 4.757 | 5.772 | 6.581 | 6.438 | 5.659 | 5.884 | 6.151 |
| Equity | 714 | 977 | 1.500 | 1.892 | 2.168 | 2.809 | 3.454 | 4.043 | 4.888 | 5.345 | 5.608 | 5.014 | 5.483 | 5.703 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 432 | -261 | 507 | 563 | 561 | 681 | 732 | 712 | 883 | 1.236 | 829 | 645 | 401 | 448 |
| Total debt | 432 | -261 | 507 | 563 | 561 | 681 | 732 | 712 | 883 | 1.236 | 829 | 645 | 401 | 448 |
EBITDA margin
57.6%
This company
15.8%
Market median
+265% vs market
20122025
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
20122025
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
20122025
Net profit margin
46.4%
This company
8.1%
Market median
+473% vs market
20122025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20122025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MR Management | Management | 2009 | — | — |
AM Management | Management | 2010 | — | — |
KA Management | Management | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Unisiro Group ApS | Company | 100.0% | 100.0% | 2019 |
Unimenco Holding ApS | Company | 50.0% | 50.0% | 2019 |
Unimenco Holding ApS | Company | 50.0% | 50.0% | 2019 |
UNIMENCO A/S | Company | 50.0% | 50.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Unisiro Group ApS
TESTDIG ApS Board members of TESTDIG ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikkel Roed | Management | 0 companies |
| Anders Michael Roed | Management | 0 companies |
| Klaus Andersen | Management | 0 companies |